Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

A group has developed therapies that show promise for treating cancer and various other conditions.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

PEGylated thymosin β4 shows promise for treating heart attacks effectively.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

The treatment is safe and shows promise for metastatic breast cancer.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Immunoadsorption successfully treated a man's resistant polymyositis.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Rituximab may cause skin issues, but baricitinib can help improve them.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.